ResearcherNational Cancer CenterNo recent work listed
Eun Kyung Hong
Matched on OpenAlex author ID A5105838834. Sources: OpenAlex.
Their work
- Papers
- 10 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 29
2011: 2 papers · 2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: 2 papers · 2020: none · 2021: 1 paper
Papers 10
- Overall survival of pancreatic ductal adenocarcinoma is doubled by Aldh7a1 deletion in the KPC mouse. Co-author DOI 10.7150/thno.53935↗
- Validation of the American Joint Committee on Cancer 8th edition staging system for the pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.ejso.2019.06.002↗
- Cytopathological results of initial endoscopic ultrasound-guided fine needle aspiration for primary mass and prognosis in pancreatic cancer patients. Co-author DOI 10.1111/cyt.12675↗
- Favorable glycemic response after pancreatoduodenectomy in both patients with pancreatic cancer and patients with non-pancreatic cancer. Co-author DOI 10.1097/md.0000000000010590↗
- Induction Chemotherapy with Gemcitabine and Cisplatin Followed by Simultaneous Integrated Boost-Intensity Modulated Radiotherapy with Concurrent Gemcitabine fo… Co-author DOI 10.4143/crt.2016.495↗
- Efficacy of pancreatic exocrine replacement therapy for patients with unresectable pancreatic cancer in a randomized trial. Co-author DOI 10.1016/j.pan.2016.09.001↗
- Risk of pancreatic cancer in relation to ABO blood group and hepatitis C virus infection in Korea: a case-control study. Last author DOI 10.3346/jkms.2013.28.2.247↗
- Multiple primary malignant neoplasms in pancreatic cancer patients: a single-center experience in Korea. Co-author DOI 10.1097/mpa.0b013e3182374d65↗
- CA 19-9 level as indicator of early distant metastasis and therapeutic selection in resected pancreatic cancer. Co-author DOI 10.1016/j.ijrobp.2010.10.011↗
- Pretreatment carbohydrate antigen 19-9 level indicates tumor response, early distant metastasis, overall survival, and therapeutic selection in localized and u… Co-author DOI 10.1016/j.ijrobp.2011.02.063↗
Closest collaborators
The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Sung‐Sik Han · 10 shared papers, 2011–2021 · strength 0.60
- Paper Overall survival of pancreatic ductal adenocarcinoma is doubled by Aldh7a1 deletion in the KPC mouse. DOI 10.7150/thno.53935↗
- Paper Cytopathological results of initial endoscopic ultrasound-guided fine needle aspiration for primary mass and prognosis … DOI 10.1111/cyt.12675↗
- Paper Validation of the American Joint Committee on Cancer 8th edition staging system for the pancreatic ductal adenocarcinom… DOI 10.1016/j.ejso.2019.06.002↗
- Sang Myung Woo · 10 shared papers, 2011–2021 · strength 0.60
- Paper Overall survival of pancreatic ductal adenocarcinoma is doubled by Aldh7a1 deletion in the KPC mouse. DOI 10.7150/thno.53935↗
- Paper Cytopathological results of initial endoscopic ultrasound-guided fine needle aspiration for primary mass and prognosis … DOI 10.1111/cyt.12675↗
- Paper Validation of the American Joint Committee on Cancer 8th edition staging system for the pancreatic ductal adenocarcinom… DOI 10.1016/j.ejso.2019.06.002↗
- Sang‐Jae Park · 9 shared papers, 2011–2019 · strength 0.48
- Paper Cytopathological results of initial endoscopic ultrasound-guided fine needle aspiration for primary mass and prognosis … DOI 10.1111/cyt.12675↗
- Paper Validation of the American Joint Committee on Cancer 8th edition staging system for the pancreatic ductal adenocarcinom… DOI 10.1016/j.ejso.2019.06.002↗
- Paper Favorable glycemic response after pancreatoduodenectomy in both patients with pancreatic cancer and patients with non-p… DOI 10.1097/md.0000000000010590↗
- Woo Jin Lee · 8 shared papers, 2011–2019 · strength 0.41
- Paper Cytopathological results of initial endoscopic ultrasound-guided fine needle aspiration for primary mass and prognosis … DOI 10.1111/cyt.12675↗
- Paper Validation of the American Joint Committee on Cancer 8th edition staging system for the pancreatic ductal adenocarcinom… DOI 10.1016/j.ejso.2019.06.002↗
- Paper Induction Chemotherapy with Gemcitabine and Cisplatin Followed by Simultaneous Integrated Boost-Intensity Modulated Rad… DOI 10.4143/crt.2016.495↗
- Tae Hyun Kim · 7 shared papers, 2011–2019 · strength 0.33
- Paper Cytopathological results of initial endoscopic ultrasound-guided fine needle aspiration for primary mass and prognosis … DOI 10.1111/cyt.12675↗
- Paper Induction Chemotherapy with Gemcitabine and Cisplatin Followed by Simultaneous Integrated Boost-Intensity Modulated Rad… DOI 10.4143/crt.2016.495↗
- Paper Efficacy of pancreatic exocrine replacement therapy for patients with unresectable pancreatic cancer in a randomized tr… DOI 10.1016/j.pan.2016.09.001↗
- Jae-Seon Lee · 1 shared paper, 2021 · strength 0.12
- Soo‐Youl Kim · 1 shared paper, 2021 · strength 0.12
- Hyonchol Jang · 1 shared paper, 2021 · strength 0.12
- Jaekyoung Son · 1 shared paper, 2021 · strength 0.12
- Yun‐Hee Kim · 2 shared papers, 2016–2017 · strength 0.11
- Paper Induction Chemotherapy with Gemcitabine and Cisplatin Followed by Simultaneous Integrated Boost-Intensity Modulated Rad… DOI 10.4143/crt.2016.495↗
- Paper Efficacy of pancreatic exocrine replacement therapy for patients with unresectable pancreatic cancer in a randomized tr… DOI 10.1016/j.pan.2016.09.001↗
- Jung Hwan Lee · 1 shared paper, 2019 · strength 0.10
- Jong-Chan Lee · 1 shared paper, 2019 · strength 0.08
- Yoo‐Seok Yoon · 1 shared paper, 2019 · strength 0.08
- Ho‐Seong Han · 1 shared paper, 2019 · strength 0.08
- Dong Woo Shin · 1 shared paper, 2019 · strength 0.08
- Jin‐Hyeok Hwang · 1 shared paper, 2019 · strength 0.08
- Jaihwan Kim · 1 shared paper, 2019 · strength 0.08
- Joong‐Won Park · 3 shared papers, 2011–2012 · strength 0.08
- Paper Multiple primary malignant neoplasms in pancreatic cancer patients: a single-center experience in Korea. DOI 10.1097/mpa.0b013e3182374d65↗
- Paper CA 19-9 level as indicator of early distant metastasis and therapeutic selection in resected pancreatic cancer. DOI 10.1016/j.ijrobp.2010.10.011↗
- Paper Pretreatment carbohydrate antigen 19-9 level indicates tumor response, early distant metastasis, overall survival, and … DOI 10.1016/j.ijrobp.2011.02.063↗
- Seo Young Sohn · 1 shared paper, 2018 · strength 0.07
- Min Kyeong Kim · 1 shared paper, 2017 · strength 0.06
- Kyong‐Ah Yoon · 1 shared paper, 2017 · strength 0.06
- Sun‐Young Kong · 1 shared paper, 2017 · strength 0.06
- So Young Kim · 1 shared paper, 2016 · strength 0.05
- Dae Yong Kim · 2 shared papers, 2011 · strength 0.05
- Paper CA 19-9 level as indicator of early distant metastasis and therapeutic selection in resected pancreatic cancer. DOI 10.1016/j.ijrobp.2010.10.011↗
- Paper Pretreatment carbohydrate antigen 19-9 level indicates tumor response, early distant metastasis, overall survival, and … DOI 10.1016/j.ijrobp.2011.02.063↗
- Tae Yoo · 2 shared papers, 2011 · strength 0.05
- Paper CA 19-9 level as indicator of early distant metastasis and therapeutic selection in resected pancreatic cancer. DOI 10.1016/j.ijrobp.2010.10.011↗
- Paper Pretreatment carbohydrate antigen 19-9 level indicates tumor response, early distant metastasis, overall survival, and … DOI 10.1016/j.ijrobp.2011.02.063↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.